Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia
Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and Dysfunctions
Related content
Urinary Tract Infections (UTI)
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review
Eur Urol
Creta M, Russo GI, Bhojani N, Drake MJ, Gratzke C, Peyronnet B, Roehrborn C, Tikkinen KAO, Cornu JN, Fusco F
doi: 10.1016/j.eururo.2024.04.031
Urinary Tract Infections (UTI)
Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms
Prostate Cancer Prostatic Dis
Gravas S, De Nunzio C, Campos Pinheiro L, Ponce de León J, Skriapas K, Milad Z, Lombardo R, Medeiros M, Makrides P, Samarinas M, Gacci M
doi: 10.1038/s41391-024-00857-5
Lower Urinary Tract Symptoms
Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
Prostate
Schmit S, Malshy K, Ochsner A, Golijanin B, Tucci C, Braunagel T, Golijanin D, Pareek G, Hyams E
doi: 10.1002/pros.24772
Benign Prostatic Hyperplasia (BPH)
Single-port transvesical simple prostatectomy for the surgical treatment of benign prostatic hyperplasia: functional and continence outcomes
Prostate Cancer Prostatic Dis
Pacini M, Lambertini L, Avesani G, Torres Anguiano JR, Morgantini L, Martin A, Sauer Calvo R, Haberal HB, Bignante G, Minervini A, Zucchi A, Bartoletti R, Crivellaro S
doi: 10.1038/s41391-024-00923-y
Benign Prostatic Hyperplasia (BPH)
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
J Urol
Staskin D, Owens-Grillo J, Thomas E, Rovner E, Cline K, Mujais S
doi: 10.1097/JU.0000000000003999
COMMENTED
Erectile and Sexual Functions and Dysfunctions
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Clin Endocrinol Metab
Wittert GA, Robledo KP, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Bracken K, Allan CA, Jesudason D, Jenkins A, Januszewski AS, Grossmann M
doi: 10.1210/clinem/dgaf060
Lower Urinary Tract SymptomsFurther Publications Urology
Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms
Eur Urol
Baboudjian M, Hashim H, Bhatt N, Creta M, De Nunzio C, Gacci M, Herrmann T, Karavitakis M, Malde S, Moris L, Netsch C, Rieken M, Sakalis V, Schouten N, Tutolo M, Cornu JN
doi: 10.1016/j.eururo.2024.04.004
Benign Prostatic Hyperplasia (BPH)
Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
Prostate
Jirásko M, Viták R, Pecen L, Pinkeová A, Tkáč J, Bertók T, Bergman N, Kučera R
doi: 10.1002/pros.24801
Benign Prostatic Hyperplasia (BPH)
Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis
Prostate Cancer Prostatic Dis
Alberti A, Lo Re M, Nicoletti R, Polverino P, Cadenar A, Ciaralli E, Solazzi F, Giustozzi B, Sessa F, Rivetti A, Campi R, Sebastianelli A, Serni S, Gacci M
doi: 10.1038/s41391-025-00952-1